ARCHIVES

Former NCI, FDA Chief Andrew Von Eschenbach Appointed to NCCN Foundation Board

This article is from The Cancer Letter archive.

Vol. 37 No. 24 | June 17, 2011

Download PDF Visit The Full Archive

Related Articles

NCI Director May Alert Cancer Panel to Freeze On GS-13 Promotion

November 4, 1994

AC To Refuse Government Help In Future Projects

November 24, 1978

Drugs and Targets: EU approves Imbruvica in MCL, CLL

October 24, 2014

In Brief: It’s Finally Official: DRCCA Name Changed To DCPC, Old DCCP Is Div. Of Cancer Etiology

December 9, 1983

Finasteride Does Not Affect Quality of Life, Says Study

September 28, 2012

NeoRx Suspends Accrual, Treatment In Phase III trial Using STR For Myeloma.

December 1, 2000